Ace gene I/D polymorphism and sarcoidosis pulmonary disease severity. 2001

D S McGrath, and P J Foley, and M Petrek, and L Izakovicova-Holla, and V Kolek, and S Veeraraghavan, and P A Lympany, and P Pantelidis, and A Vasku, and A U Wells, and K I Welsh, and R M Du Bois, and V Dolek
Interstitial Lung Disease Unit, Department of Occupational and Environmental Medicine, National Heart and Lung Institute, Imperial College of Science, Technology, and Medicine, London, SW3 6LR, UK.

Previous studies of the insertion/deletion (I/D) polymorphism of the angiotensin-converting enzyme (ACE) gene in sarcoidosis have revealed both ethnic heterogeneity of I/D frequencies and controversy surrounding the association between the polymorphism and severity of disease. The objective of this study was, therefore, to clarify the role of the ACE I/D polymorphism in (1) disease susceptibility, (2) pulmonary disease severity (with particular reference to pulmonary fibrosis), and (3) pulmonary disease progression, in two distinct European sarcoidosis populations. Standard chest radiographic staging was performed on 118 UK and 56 Czech white patients with sarcoidosis at 2 yr from presentation. Pulmonary function data were analyzed, and patients were then categorized according to disease severity. A PCR-SSP assay was used to determine the ACE I/D genotype of each patient studied. The I/D allele frequencies from these patients were compared with frequencies from ethnically matched UK (n = 386) and Czech (n = 179) control subjects using a chi-square contingency table. No significant differences were seen in the distribution of the ACE I/D genotypes, allele frequencies or phenotype frequencies. Furthermore, no association was found between the ACE I/D polymorphism and pulmonary disease severity, fibrosis, and progression. We conclude that the ACE I/D polymorphism has no role in sarcoidosis susceptibility in European whites and that it is not a regulatory variant in this disease.

UI MeSH Term Description Entries
D007703 Peptidyl-Dipeptidase A A peptidyl-dipeptidase that catalyzes the release of a C-terminal dipeptide, oligopeptide-|-Xaa-Yaa, when Xaa is not Pro, and Yaa is neither Asp nor Glu. Thus, conversion of ANGIOTENSIN I to ANGIOTENSIN II, with increase in vasoconstrictor activity, but no action on angiotensin II. It is also able to inactivate BRADYKININ, a potent vasodilator; and has a glycosidase activity which releases GPI-anchored proteins from the membrane by cleaving the mannose linkage in the GPI moiety. (From https://www.uniprot.org April 15, 2020). ACE1 Angiotensin-Converting Enzyme 1,ACE1 Protein,Angiotensin Converting Enzyme,Angiotensin Converting Enzyme 1,Antigens, CD143,CD143 Antigens,Dipeptidyl Carboxypeptidase I,Kininase II,Peptidase P,Angiotensin I-Converting Enzyme,Carboxycathepsin,Dipeptidyl Peptidase A,Kininase A,ACE1 Angiotensin Converting Enzyme 1,Angiotensin I Converting Enzyme,Carboxypeptidase I, Dipeptidyl,Peptidyl Dipeptidase A
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011110 Polymorphism, Genetic The regular and simultaneous occurrence in a single interbreeding population of two or more discontinuous genotypes. The concept includes differences in genotypes ranging in size from a single nucleotide site (POLYMORPHISM, SINGLE NUCLEOTIDE) to large nucleotide sequences visible at a chromosomal level. Gene Polymorphism,Genetic Polymorphism,Polymorphism (Genetics),Genetic Polymorphisms,Gene Polymorphisms,Polymorphism, Gene,Polymorphisms (Genetics),Polymorphisms, Gene,Polymorphisms, Genetic
D003604 Czechoslovakia Created as a republic in 1918 by Czechs and Slovaks from territories formerly part of the Austro-Hungarian Empire. The country split into the Czech Republic and Slovakia 1 January 1993.
D004251 DNA Transposable Elements Discrete segments of DNA which can excise and reintegrate to another site in the genome. Most are inactive, i.e., have not been found to exist outside the integrated state. DNA transposable elements include bacterial IS (insertion sequence) elements, Tn elements, the maize controlling elements Ac and Ds, Drosophila P, gypsy, and pogo elements, the human Tigger elements and the Tc and mariner elements which are found throughout the animal kingdom. DNA Insertion Elements,DNA Transposons,IS Elements,Insertion Sequence Elements,Tn Elements,Transposable Elements,Elements, Insertion Sequence,Sequence Elements, Insertion,DNA Insertion Element,DNA Transposable Element,DNA Transposon,Element, DNA Insertion,Element, DNA Transposable,Element, IS,Element, Insertion Sequence,Element, Tn,Element, Transposable,Elements, DNA Insertion,Elements, DNA Transposable,Elements, IS,Elements, Tn,Elements, Transposable,IS Element,Insertion Element, DNA,Insertion Elements, DNA,Insertion Sequence Element,Sequence Element, Insertion,Tn Element,Transposable Element,Transposable Element, DNA,Transposable Elements, DNA,Transposon, DNA,Transposons, DNA
D005260 Female Females
D006113 United Kingdom Country in northwestern Europe including Great Britain and the northern one-sixth of the island of Ireland, located between the North Sea and north Atlantic Ocean. The capital is London. Great Britain,Isle of Man
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

D S McGrath, and P J Foley, and M Petrek, and L Izakovicova-Holla, and V Kolek, and S Veeraraghavan, and P A Lympany, and P Pantelidis, and A Vasku, and A U Wells, and K I Welsh, and R M Du Bois, and V Dolek
January 2012, Tuberkuloz ve toraks,
D S McGrath, and P J Foley, and M Petrek, and L Izakovicova-Holla, and V Kolek, and S Veeraraghavan, and P A Lympany, and P Pantelidis, and A Vasku, and A U Wells, and K I Welsh, and R M Du Bois, and V Dolek
January 2005, Scandinavian journal of clinical and laboratory investigation,
D S McGrath, and P J Foley, and M Petrek, and L Izakovicova-Holla, and V Kolek, and S Veeraraghavan, and P A Lympany, and P Pantelidis, and A Vasku, and A U Wells, and K I Welsh, and R M Du Bois, and V Dolek
December 2015, Cytotechnology,
D S McGrath, and P J Foley, and M Petrek, and L Izakovicova-Holla, and V Kolek, and S Veeraraghavan, and P A Lympany, and P Pantelidis, and A Vasku, and A U Wells, and K I Welsh, and R M Du Bois, and V Dolek
August 2012, BMC pulmonary medicine,
D S McGrath, and P J Foley, and M Petrek, and L Izakovicova-Holla, and V Kolek, and S Veeraraghavan, and P A Lympany, and P Pantelidis, and A Vasku, and A U Wells, and K I Welsh, and R M Du Bois, and V Dolek
August 1997, Lancet (London, England),
D S McGrath, and P J Foley, and M Petrek, and L Izakovicova-Holla, and V Kolek, and S Veeraraghavan, and P A Lympany, and P Pantelidis, and A Vasku, and A U Wells, and K I Welsh, and R M Du Bois, and V Dolek
November 2004, Aviation, space, and environmental medicine,
D S McGrath, and P J Foley, and M Petrek, and L Izakovicova-Holla, and V Kolek, and S Veeraraghavan, and P A Lympany, and P Pantelidis, and A Vasku, and A U Wells, and K I Welsh, and R M Du Bois, and V Dolek
April 1996, Journal of medical genetics,
D S McGrath, and P J Foley, and M Petrek, and L Izakovicova-Holla, and V Kolek, and S Veeraraghavan, and P A Lympany, and P Pantelidis, and A Vasku, and A U Wells, and K I Welsh, and R M Du Bois, and V Dolek
February 2009, Neurology,
D S McGrath, and P J Foley, and M Petrek, and L Izakovicova-Holla, and V Kolek, and S Veeraraghavan, and P A Lympany, and P Pantelidis, and A Vasku, and A U Wells, and K I Welsh, and R M Du Bois, and V Dolek
April 2016, Archives of medical science : AMS,
D S McGrath, and P J Foley, and M Petrek, and L Izakovicova-Holla, and V Kolek, and S Veeraraghavan, and P A Lympany, and P Pantelidis, and A Vasku, and A U Wells, and K I Welsh, and R M Du Bois, and V Dolek
January 2002, Klinicheskaia meditsina,
Copied contents to your clipboard!